492
Views
1
CrossRef citations to date
0
Altmetric
Research Articles

Deleterious single nucleotide polymorphisms (SNPs) of human IFNAR2 gene facilitate COVID-19 severity in patients: a comprehensive in silico approach

ORCID Icon, , & ORCID Icon
Pages 11173-11189 | Received 16 Apr 2021, Accepted 10 Jul 2021, Published online: 06 Aug 2021
 

Abstract

In humans, the dimeric receptor complex IFNAR2-IFNAR1 accelerates cellular response triggered by type I interferon (IFN) family proteins in response to viral infection including Coronavirus infection. Studies have revealed the association of the IFNAR2 gene with severe illness in Coronavirus infection and indicated the association of genomic variants, i.e. single nucleotide polymorphisms (SNPs). However, comprehensive analysis of SNPs of the IFNAR2 gene has not been performed in both coding and non-coding region to find the causes of loss of function of IFNAR2 in COVID-19 patients. In this study, we have characterized coding SNPs (nsSNPs) of IFNAR2 gene using different bioinformatics tools and identified deleterious SNPs. We found 9 nsSNPs as pathogenic and disease-causing along with a decrease in protein stability. We employed molecular docking analysis that showed 5 nsSNPs to decrease binding affinity to IFN. Later, MD simulations showed that P136R mutant may destabilize crucial binding with the IFN molecule in response to COVID-19. Thus, P136R is likely to have a high impact on disrupting the structure of the IFNAR2 protein. GTEx portal analysis predicted 14 sQTLs and 5 eQTLs SNPs in lung tissues hampering the post-transcriptional modification (splicing) and altering the expression of the IFNAR2 gene. sQTLs and eQTLs SNPs potentially explain the reduced IFNAR2 production leading to severe diseases. These mutants in the coding and non-coding region of the IFNAR2 gene can help to recognize severe illness due to COVID 19 and consequently assist to develop an effective drug against the infection.

Communicated by Ramaswamy H. Sarma

Acknowledgements

The authors acknowledge sincere support provided by Md. Shahadat Hossain and the Lab at Department of Biotechnology and Genetic Engineering, Noakhali Science and Technology University, Noakhali, Bangladesh.

Disclosure statement

No potential conflict of interest was reported by the author(s).

Correction Statement

This article has been republished with minor changes. These changes do not impact the academic content of the article.

Additional information

Notes on contributors

Shamima Akter

S.A, and M.S.I conceived and designed the study. S.A. collected the data and analyzed all the SNPs using in silico tools. A.S.R performed the Molecular Docking and M.I.Q.T performed the Molecular dynamics simulation. S.A, M.S.I, A.S.R, and M.I.Q.T discussed and interpreted the results. S.A drafted the manuscript. S.A, M.S.I, A.S.R, and M.I.Q.T revised the manuscript. All authors read and agreed to the submitted version of the manuscript.

Md Sajedul Islam

S.A, and M.S.I conceived and designed the study. S.A. collected the data and analyzed all the SNPs using in silico tools. A.S.R performed the Molecular Docking and M.I.Q.T performed the Molecular dynamics simulation. S.A, M.S.I, A.S.R, and M.I.Q.T discussed and interpreted the results. S.A drafted the manuscript. S.A, M.S.I, A.S.R, and M.I.Q.T revised the manuscript. All authors read and agreed to the submitted version of the manuscript.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.